Cellular and Molecular Effects of Eribulin in Preclinical Models of Hematologic Neoplasms

SIMPLE SUMMARY: Hematologic neoplasms comprise a heterogeneous group of diseases that interfere with normal blood production. Treating patients who fail available therapies for these diseases is an ongoing challenge. Thus, the search for new treatment options is urgent, and drug repositioning is eme...

Descripción completa

Detalles Bibliográficos
Autores principales: Vicari, Hugo Passos, Lima, Keli, Costa-Lotufo, Leticia Veras, Machado-Neto, João Agostinho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776580/
https://www.ncbi.nlm.nih.gov/pubmed/36551566
http://dx.doi.org/10.3390/cancers14246080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776580/
https://www.ncbi.nlm.nih.gov/pubmed/36551566
http://dx.doi.org/10.3390/cancers14246080

Ejemplares similares